Medication Safety

Safe
Deprescribing

The thoughtful, supervised process of reducing or stopping psychiatric medications that no longer provide meaningful benefit — or whose risks now outweigh their value. Dr. Farkas's pharmaceutical research background makes her exceptionally capable of this nuanced, undervalued work.

Schedule an Evaluation All Treatments

⏱

60–90 min evaluation

🧠

MD/PhD neuroscience

💳

Aetna & Cigna

💻

SC · NY · VA telehealth

Deprescribing

Deprescribing Targets

Benzodiazepines · Unnecessary antipsychotics · Redundant antidepressants · Oversedating agents · Polypharmacy simplification

MD/PhD-level prescribing — not pattern-matching

Measurement-based tracking at every follow-up

"No harm" philosophy — side effects are solved, not accepted

In-network: Aetna & Cigna

📅 Request an appointment → 📞 917-267-9678

Medication Safety

How Dr. Farkas approaches
Deprescribing

Evidence-based, neurobiologically-informed. Every prescribing decision is grounded in mechanism — not tradition or trial-and-error.

🔍

Necessity Review

Every medication is evaluated: What was the original indication? Is it still present? Is this drug still contributing? Many medications prescribed years ago have no clear current rationale.

📊

Benefit-Risk Reassessment

The risk-benefit calculation changes over time. A medication appropriate at 35 may be inappropriate at 65. Dr. Farkas reassesses continuously.

🌿

Benzodiazepine Tapering

Evidence-based, gradual benzodiazepine tapers — avoiding withdrawal while reducing dependency and cognitive side effects.

🔬

Antipsychotic Reduction

For patients on atypical antipsychotics without clear ongoing indication — a careful, monitored reduction plan.

🧬

Polypharmacy Simplification

Four or more psychiatric medications often means historical accumulation rather than rational polypharmacy. Simplification improves tolerability and clarity.

🤝

Collaborative Process

Deprescribing is never imposed — it's a collaborative decision with clear explanation of rationale, expected timeline, and what to watch for.

The Process

From evaluation to
lasting results

Comprehensive Evaluation

60–90 minutes covering your full psychiatric, medical, and medication history. Nothing skipped — accuracy before action.

Neurobiological Strategy

Treatment selection based on mechanism, your history, and what's failed before. Not the next name in the algorithm.

Regular Monitoring

Validated outcome measures at every visit. Objective data drives every adjustment — symptom improvement and side effect burden both tracked.

Long-Term Optimization

Treatment evolves as your life does. Regular reviews ensure you're always on the lowest effective regimen with the highest quality of life.

Conditions Treated

Deprescribing is used to treat
these conditions

PolypharmacyBenzodiazepine DependencyUnnecessary Antipsychotic UseGeriatric PsychiatryTreatment Review

Don't see your condition? View all 28 conditions treated →

Getting Started

What to expect at
your first appointment

New patient evaluations are 60–90 minutes — never a rushed intake. Dr. Farkas takes your full psychiatric, medical, and medication history before making any prescribing decisions. You'll leave with a clear diagnosis, a treatment plan that makes sense to you, and a follow-up already scheduled.

Telehealth available throughout South Carolina, New York, and Virginia. In-person at our Hilton Head Island, SC office.

60–90 minute evaluation — not a template intake

Full review of prior medication history and what's failed

Neurobiologically-informed prescribing, not trial-and-error

Measurement-based tracking at every follow-up visit

No-harm philosophy — side effects are solved, not tolerated

Schedule an Evaluation BMJ: Deprescribing in Psychiatry ↗

Other Treatments

💊

Medication Management

→ 🌊

Treatment-Resistant Protocols